Literature DB >> 18973576

C1 neurons in the rat rostral ventrolateral medulla differentially express vesicular monoamine transporter 2 in soma and axonal compartments.

C P Sevigny1, J Bassi, A G Teschemacher, K S Kim, D A Williams, C R Anderson, A M Allen.   

Abstract

Vesicular monoamine transporter 2 (VMAT2) packages biogenic amines into large dense core and synaptic vesicles for either somatodendritic or synaptic release from neurons of the CNS. Whilst the distribution of VMAT2 has been well characterized in many catecholaminergic cell groups, its localization amongst C1 adrenergic neurons in the medulla has not been examined in detail. Within the rostral ventrolateral medulla (RVLM), C1 neurons are a group of barosensitive, adrenergic neurons. Rostral C1 cells project to the thoracic spinal cord and are considered sympathetic premotor neurons. The majority of caudal C1 cells project rostrally to regions such as the hypothalamus. The present study sought to quantitate the somatodendritic expression of VMAT2 in C1 neurons, and to assess the subcellular distribution of the transporter. Immunoreactivity for VMAT2 occurred in 31% of C1 soma, with a high proportion of these in the caudal part of the RVLM. Retrograde tracing studies revealed that only two of 43 bulbospinal C1 neurons contained faint VMAT2-immunoreactivity, whilst 88 +/- 5% of rostrally projecting neurons were VMAT2-positive. A lentivirus, designed to express green fluorescent protein exclusively in noradrenergic and adrenergic neurons, was injected into the RVLM to label C1 neurons. Eighty-three percent of C1 efferents that occurred in close proximity to sympathetic preganglionic neurons within the T(3) intermediolateral cell column contained VMAT2-immunoreactivity. These data demonstrate differential distribution of VMAT2 within different subpopulations of C1 neurons and suggest that this might reflect differences in somatodendritic vs. synaptic release of catecholamines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973576     DOI: 10.1111/j.1460-9568.2008.06445.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  6 in total

1.  Monosynaptic glutamatergic activation of locus coeruleus and other lower brainstem noradrenergic neurons by the C1 cells in mice.

Authors:  Benjamin B Holloway; Ruth L Stornetta; Genrieta Bochorishvili; Alev Erisir; Kenneth E Viar; Patrice G Guyenet
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

2.  Vesicular glutamate transporter 2 is required for the respiratory and parasympathetic activation produced by optogenetic stimulation of catecholaminergic neurons in the rostral ventrolateral medulla of mice in vivo.

Authors:  Stephen B G Abbott; Benjamin B Holloway; Kenneth E Viar; Patrice G Guyenet
Journal:  Eur J Neurosci       Date:  2013-11-18       Impact factor: 3.386

3.  Glutamatergic neurotransmission between the C1 neurons and the parasympathetic preganglionic neurons of the dorsal motor nucleus of the vagus.

Authors:  Seth D DePuy; Ruth L Stornetta; Genrieta Bochorishvili; Karl Deisseroth; Ilana Witten; Melissa Coates; Patrice G Guyenet
Journal:  J Neurosci       Date:  2013-01-23       Impact factor: 6.167

4.  Afferent and efferent connections of C1 cells with spinal cord or hypothalamic projections in mice.

Authors:  Ruth L Stornetta; M Andrews Inglis; Kenneth E Viar; Patrice G Guyenet
Journal:  Brain Struct Funct       Date:  2015-11-11       Impact factor: 3.270

5.  Recording, labeling, and transfection of single neurons in deep brain structures.

Authors:  Bowen Dempsey; Anita J Turner; Sheng Le; Qi-Jian Sun; Lama Bou Farah; Andrew M Allen; Ann K Goodchild; Simon McMullan
Journal:  Physiol Rep       Date:  2015-01-19

6.  Tyrosine hydroxylase phosphorylation in catecholaminergic brain regions: a marker of activation following acute hypotension and glucoprivation.

Authors:  Hanafi A Damanhuri; Peter G R Burke; Lin K Ong; Larisa Bobrovskaya; Phillip W Dickson; Peter R Dunkley; Ann K Goodchild
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.